| Absorption |
| Blood-Brain Barrier | BBB+ | 0.9712 |
| Human Intestinal Absorption | HIA+ | 1.0000 |
| Caco-2 Permeability | Caco2+ | 0.8787 |
| P-glycoprotein Substrate | Non-substrate | 0.7553 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.9465 |
| Non-inhibitor | 0.9583 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.8636 |
| Distribution |
| Subcellular localization | Mitochondria | 0.7797 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.8134 |
| CYP450 2D6 Substrate | Non-substrate | 0.9406 |
| CYP450 3A4 Substrate | Non-substrate | 0.7731 |
| CYP450 1A2 Inhibitor | Inhibitor | 0.7888 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.8860 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.9525 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.8897 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.9817 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.7227 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9575 |
| Non-inhibitor | 0.9739 |
| AMES Toxicity | Non AMES toxic | 0.9885 |
| Carcinogens | Carcinogens | 0.5132 |
| Fish Toxicity | High FHMT | 0.8015 |
| Tetrahymena Pyriformis Toxicity | High TPT | 0.9900 |
| Honey Bee Toxicity | High HBT | 0.7587 |
| Biodegradation | Ready biodegradable | 0.9266 |
| Acute Oral Toxicity | III | 0.9356 |
| Carcinogenicity (Three-class) | Non-required | 0.6038 |